The Booming Chitosan Market, Valued at $7.84 Billion in 2025 is Forecast to Exceed $58 Billion by 2035 - Asia's Rising Cosmetic Industry to Propel Rapid Chitosan Market Expansion - ResearchAndMarkets.com
The Booming Chitosan Market, Valued at $7.84 Billion in 2025 is Forecast to Exceed $58 Billion by 2035 - Asia's Rising Cosmetic Industry to Propel Rapid Chitosan Market Expansion - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Chitosan Market Forecast Till 2035, Distribution by Type of Source, Type of Grade, Application, Company Size, Type of Business Model, Type of End User, and Geographical Regions: Industry Trends and Global Forecasts" has been added to ResearchAndMarkets.com's offering.
The global chitosan market is projected to grow from USD 7.84 billion to USD 58.54 billion by 2035, marking a CAGR of 20.05% over the forecast period. This growth is driven by the increasing application of chitosan across various industries, including pharmaceuticals, food and beverage, and agriculture, owing to its beneficial properties such as anticoagulation, biodegradability, and biocompatibility.
Chitosan, derived from shellfish shells, features non-toxicity and hydrophobicity, making it ideal for wastewater treatment. Innovations like chitosan nanoparticles for plant gene transfer further fuel its demand.
Market Segmentation
Type of Source: The market is segmented into crabs, prawns, shrimps, squids, and others. Shrimps currently lead due to the substantial waste from shrimp shells, which is cost-effective and eco-friendly for producing cosmetic additives, water treatments, and textile solutions. Squid-based chitosan is expected to grow significantly, owing to its biocompatibility and suitability for pharmaceuticals.
Type of Grade: Market segments include industrial, food, and pharmaceutical grades. Industrial grade dominates due to its widespread use in wastewater management and as a clarifying agent in food and beverages. Pharmaceutical grade is anticipated to grow faster, driven by its deployment in drug delivery systems and tissue engineering.
Application: Applications include wastewater treatment, dietary supplements, cosmetics, pharmaceuticals, and others. Currently, wastewater treatment holds the largest share, leveraging chitosan as a flocculant. Pharmaceutical and biomedical applications are expected to witness higher growth due to chitosan's efficacy in wound care and tissue engineering.
Company Size: Segments include large enterprises and SMEs. Large enterprises dominate the market due to robust R&D, diverse product offerings, and extensive production capabilities. However, startups are entering the market, signaling future growth.
End User: Categories include agriculture, pharmaceuticals, cosmetics, water treatment, and food & beverage. Water treatment leads the segment owing to chitosan's role as a flocculant and heavy metal ion scavenger. The pharmaceutical segment is poised for high growth due to its use in advanced drug delivery and tissue engineering systems.
Geographical Regions: The market is segregated into North America, Europe, Asia, Latin America, Middle East, and Africa. North America currently leads, driven by bio-based cosmetics demand and organic skincare preferences. Asia is expected to record a higher CAGR, fueled by cosmetic industry expansion and bio-based chemical investments.
Comprehensive Research Coverage:
- In-depth market sizing and opportunity analysis across key segments.
- Detailed competitive landscape evaluation.
- Company profiles with key details and market strategies.
- SWOT and value chain analyses to outline market dynamics.
Key Insights and Strategic Benefits:
- Identification of market leaders and dynamics influencing market evolution.
- Opportunities and challenges within key market segments.
- Comprehensive revenue projections to guide stakeholders in strategic market positioning.
Additional Offerings:
- Complimentary Excel data packs for analytical insights.
- 15% content customization and in-depth report walkthrough sessions.
- Free report updates for editions older than 6 months.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 179 |
| Forecast Period | 2025-2035 |
| Estimated Market Value (USD) in 2025 | $7.84 Billion |
| Forecasted Market Value (USD) by 2035 | $58.54 Billion |
| Compound Annual Growth Rate | 20% |
| Regions Covered | Global |
A selection of companies mentioned in this report includes, but is not limited to:
- Advanced BIOPOLYMERS AS
- Agratech
- Austanz Chitin
- CarboMer
- Chitolytic
- DuPont Corporation
- Golden-Shell Pharmaceuticals
- GTC Bio Corporation
- Heppe Medical Chitosan GmbH
- KIMICA Corporation
- Kitozyme,
- Kraeber & Co. GmbH
- Meron Group
- Marshall Marine Products
- Primex EHF
- Panvo Organics
- Qingdao Haijia Biology and Technology
- Tidal Vision
- Xianju Tengwang Chitosan Factory
- Zhejiang Aoxing Biotechnology
For more information about this report visit https://www.researchandmarkets.com/r/3rs2x6
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
